EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical, electrophysiological, cutaneous sensory, and autonomic changes in patients with multiple myeloma following bortezomib treatment

Young Gi Min, Seungjin Choi, Yoo Jin Lee, Youjin Kim, Jae-Cheol Jo, Sunyoung Kim

Annals of Clinical Neurophysiology · 31.10.2026 · 28 (2) · 67-76

DOI: 10.14253/acn.25020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Neurophysiology, erschienen am 31.10.2026. Verfasst von Young Gi Min und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ulsan University Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bortezomib-induced peripheral neuropathy (BIPN) is a significant adverse effect following bortezomib administration for multiple myeloma (MM). The clinical presentation of BIPN, its predictive factors, and the role of pre-existing neuropathy remain unclear. This study aimed to provide comprehensive clinical and electrophysiological profiles of BIPN, its baseline predictors, and the role of pre-existing neuropathy.

Methods

This prospective longitudinal observational study involved 27 patients with newly diagnosed MM. Their neurological features were assessed before and after four cycles of bortezomib-based chemotherapy using four validated outcome measures and three types of electrophysiological testing: the reduced Total Neuropathy Score (TNS-r), Composite Autonomic Symptom Score-31, Small Fiber Neuropathy Symptom Inventory Questionnaire, Korean Neuropathic Pain Questionnaire, nerve conduction studies, quantitative sensory testing, and quantitative sudomotor axon reflex testing (QSART).

Results

Bortezomib treatment significantly worsened the TNS-r (p = 0.0033), primarily due to sensory symptoms and signs, with cold pain being the most-affected sensory symptom. Significant deterioration was also observed in the sensory nerve action potential (SNAP) amplitude, cold detection threshold, and QSART score. Baseline predictors of clinically evident BIPN (TNS-r ≥3) were the ulnar compound muscle action potential amplitude, median SNAP amplitude, and QSART score. Some patients with baseline neuropathic pain or autonomic dysfunction experienced considerable improvement following treatment.

Conclusions

BIPN primarily causes sensory symptoms and axonal degeneration, and may be predicted by several baseline electrophysiological parameters. The unexpected improvement in pre-existing neuropathic pain and autonomic symptoms during chemotherapy in some patients warrants further clinical and mechanistic investigations.

Förderung

  • Ulsan University Hospital

Zitieren

APA

Min, Y. G., Choi, S., Lee, Y. J., Kim, Y., Jo, J., & Kim, S. (2026). Clinical, electrophysiological, cutaneous sensory, and autonomic changes in patients with multiple myeloma following bortezomib treatment. Annals of Clinical Neurophysiology, 28(2), 67-76. https://doi.org/10.14253/acn.25020

Vancouver

Min YG, Choi S, Lee YJ, Kim Y, Jo J, Kim S. Clinical, electrophysiological, cutaneous sensory, and autonomic changes in patients with multiple myeloma following bortezomib treatment. Annals of Clinical Neurophysiology. 2026;28(2):67-76. doi:10.14253/acn.25020

BibTeX
@article{Min2026,
  author = {Min, Young Gi and Choi, Seungjin and Lee, Yoo Jin and Kim, Youjin and Jo, Jae-Cheol and Kim, Sunyoung},
  title = {Clinical, electrophysiological, cutaneous sensory, and autonomic changes in patients with multiple myeloma following bortezomib treatment},
  journal = {Annals of Clinical Neurophysiology},
  year = {2026},
  volume = {28},
  number = {2},
  pages = {67--76},
  doi = {10.14253/acn.25020}
}
Kostenlos starten →